Local suppression of IL-17a in the lung of a model with lung cancer showed improved anti-tumor immunity featured by the enhanced IFNγ, a reduced number of T-regulatory cell and the inhibited tumor growth [31]. The gene discussed is IL17A; the disease is lung cancer.